Dr. Mohebtash is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5601 Loch Raven Blvd
Baltimore, MD 21239Phone+1 443-444-3991
Education & Training
National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 2006 - 2009
MedStar Health (Baltimore)Residency, Internal Medicine, 2003 - 2006
Tehran University of Medical Sciences School of MedicineClass of 1997
Certifications & Licensure
MD State Medical License 2006 - 2025- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification ARIA Medical Oncology EMR, Varian Medical Systems, 2014
Clinical Trials
- Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer Start of enrollment: 2011 Jan 15
- Combination Immunotherapy With Herceptin and the HER2 Vaccine NeuVax Start of enrollment: 2013 May 21
- Diarrhea Prevention and Prophylaxis With Crofelemer in HER2 Positive Breast Cancer Patients Start of enrollment: 2017 Jan 31
Publications & Presentations
PubMed
- Severe Thrombocytopenia in Infective Endocarditis.Mayuri Patel, Biplov Adhikari, Amrit Devkota, Mahsa Mohebtash
Journal of Community Hospital Internal Medicine Perspectives. 2023-01-01 - 4 citationsHALT-D: a randomized open-label phase II study of crofelemer for the prevention of chemotherapy-induced diarrhea in patients with HER2-positive breast cancer receiving...Paula R Pohlmann, Deena Graham, Tianmin Wu, Yvonne Ottaviano, Mahsa Mohebtash
Breast Cancer Research and Treatment. 2022-12-01 - 9 citationsHematologic safety of palbociclib in combination with endocrine therapy in patients with benign ethnic neutropenia and advanced breast cancer.Filipa Lynce, Matthew Blackburn, Rebecca Zhuo, Christopher Gallagher, Olwen Hahn
Cancer. 2021-10-01
Press Mentions
MedStar Health First in Maryland to Achieve National Accreditation for Rectal CancerOctober 24th, 2024- MedStar Health Cancer Program in Baltimore Earns Three-Year AccreditationMay 3rd, 2023
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
